Navigation Links
Programmed death boosts business
Date:5/8/2008

As credits crunch, recession bites, and business struggle to stay primed, researchers in Spain suggest that a more surgical approach to management and business practice is needed if a company is to survive. Writing in the International Journal of Management Practice from Inderscience Publishers, the team explains how businesses could take a cue from nature to them restructure.

Palmira Lpez-Fresno of "STIGA" in Barcelona is working with Fernando Fernndez-Gonzlez of the Hospital Central de Asturias in Oviedo to demonstrate how a process analogous to apoptosis, or programmed cell death, could help companies, and organisations, such as hospitals, removed malfunctioning or ineffective parts of their business and operations and so prevent the spread of commercial decay that could spread throughout an organisation and lead ultimately to its demise.

Programmed cell death, known in biological circles as apoptosis, is a natural process in which damaged, diseased, or otherwise unwanted cells are stimulated to undergo spontaneous self destruction. Apoptosis is a very useful process. Under normal conditions, it models the foetus, allowing growing fingers to separate for form tiny hands, for instance. Apoptosis also allows the body to eradicate errant cells that could be destructive if left to their own devices. It also keeps cell replication in check and prevents the kind of runaway cell replication that would otherwise lead to cancer.

Lpez-Fresno and Fernndez-Gonzlez explain that Business Process Reengineering (BPR) has become a fashionable and effective approach to increasing productivity through reduced process time and cost, improved quality, and greater customer satisfaction. The core emphasis of BPR is the fundamental rethinking and radical redesign of business process to achieve dramatic improvements in critical areas, they say.

However, BPR is not a panacea. The researchers add that implementing BPR is not only complex but does not guarantee good results, unless both success and failure factors are taken into account. They point out that if an organisation overlooks localised failures within, then lack of motivation, loss of credibility, financial breakdown, and other issues can spread like diseased tissue cause widespread problems and ultimately kill a business.

To stop the rot, Lpez-Fresno and Fernndez-Gonzlez suggest that business adopt apoptosis as a standard procedure within the organisation. Improvements and self-protective systems can be introduced, which they refer to as "structured and virtual mechanisms". These are embedded into each part or process within the organisation and will trigger at a specific moment, when conditions approach a tipping point, the programmed removal of that particular part or process. The assessment of a negative tipping point is based on ongoing risk assessment and validation of productivity as well as other factors. The result will be the localised programmed death of only the malfunctioning part or process.

As components processes, units, departments lose relevance and efficacy then an approach based on the biological principle of apoptosis means self-sacrifice for specific parts of the business, which may cut to the core of those people involved, but will protect the organisation as a whole and could even save its life.


'/>"/>

Contact: Fernando Fernndez-Gonzlez
fgfernando@msn.com
Inderscience Publishers
Source:Eurekalert

Related biology news :

1. UCLA stem cell researchers create heart and blood cells from reprogrammed skin cells
2. MIT-led teams unravel heparin death mystery
3. Sudden Oak Death pathogen is evolving, says new study that reconstructs the epidemic
4. Vitamin D and calcium influence cell death in the colon, researchers find
5. Stopping unwanted cell death: Implications for drug discovery
6. Death protein research secures funding for UCF scientists
7. Coral reefs and climate change: Microbes could be the key to coral death
8. From delicious to death: Understanding taste
9. Human deaths from shark attacks hit 20-year low last year
10. Marsupial lion tops African lion in fight to death
11. The birth and death of dopamine neurons: A new model for neurodegeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2016)... 2016  Extenua Inc., a pioneering developer of ... and access of ubiquitous on-premise and cloud storage, today ... Cyber.  ... C4ISR and Cyber initiatives in support of National ... technology solutions," said Steve Visconti , Extenua ...
(Date:1/13/2016)... , January 13, 2016 ... the addition of the  "India Biometrics ... & Forecast (2015-2020)"  report to ... ) has announced the addition of ... Market - Estimation & Forecast (2015-2020)" ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016   ... diagnostic products, today announced the closing of a $9 million ... Proceeds from the financing will be used to accelerate the ... for detecting early-stage pressure ulcers. United ... receiving CE Mark approval. The device,s introduction has been met ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... ... February 08, 2016 , ... Information Management Services ( ... The upgrade represents a completely new technical foundation and is so significant it ... responsive design interface, significantly increased speed for search results, a streamlined layout and a ...
(Date:2/8/2016)... Stockton has an active R&D program for the ... area, the Group has a unique research and development center ... in developing Bio Control products. Stockton ... parameters and regulatory guidelines, and is active in more than ... Stockton,s flagship product Timorex Gold ...
(Date:2/6/2016)... , ... February 06, 2016 , ... ... , The Center for Excellence in Education Sponsors Teacher Training Program , ... February 4, 2016 – The Center for Excellence in Education (CEE) will sponsor ...
(Date:2/5/2016)... 5, 2016 Amarantus BioScience Holdings, ... focused on developing products for Regenerative Medicine, Neurology and ... Disease Designation (RPDD) from the US Food and Drug ... MANF was previously granted orphan drug designation (ODD) by ... Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), ...
Breaking Biology Technology: